Cerevel Therapeutics Holdings Stock Price on February 1, 2024
| CERE Stock | USD 42.55 0.04 0.09% |
If you're considering investing in Cerevel Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cerevel Therapeutics stands at 42.55, as last reported on the 4th of May, with the highest price reaching 42.79 and the lowest price hitting 42.54 during the day. We consider Cerevel Therapeutics very steady. Cerevel Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0487, which signifies that the company had a 0.0487% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cerevel Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Cerevel Therapeutics' Downside Deviation of 0.7266, mean deviation of 0.4287, and Risk Adjusted Performance of 0.0244 to double-check if the risk estimate we provide is consistent with the expected return of 0.0339%.
At present, Cerevel Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 1.3 B, whereas Common Stock is forecasted to decline to about 17.1 K. . As of May 4, 2024, Price To Sales Ratio is expected to decline to 39.33. In addition to that, Price Earnings Ratio is expected to decline to -16.67. Cerevel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cerevel |
Sharpe Ratio = 0.0487
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CERE |
Estimated Market Risk
| 0.7 actual daily | 6 94% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Cerevel Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cerevel Therapeutics by adding it to a well-diversified portfolio.
Price Book 11.2787 | Book Value 3.715 | Enterprise Value 7.2 B | Enterprise Value Ebitda (16.76) | Shares Float 77.2 M |
Related Headline
Travere Therapeutics Headline on 1st of February 2024
Travere Therapeutics to Present at the Guggenheim 6th Annual... by finance.yahoo.com
SAN DIEGO, Feb. 01, 2024 -- Travere Therapeutics, Inc. today announced that company management will present at the Guggenheim 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 1130 a.m. ET. A live webcast will be accessible on the Investor page of Traveres website at ir.travere.comevents-presentations, and a replay will be available for up to 30 days following the event. About Travere Therapeutics At Travere Therapeutics, we are in rare for
Cerevel Therapeutics Valuation on February 1, 2024
It is possible to determine the worth of Cerevel Therapeutics on a given historical date. On February 1, 2024 Cerevel was worth 41.92 at the beginning of the trading date compared to the closed value of 41.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cerevel Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cerevel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cerevel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cerevel Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 42.10 | 42.24 | 41.82 | 41.90 | 958,198 | |
02/01/2024 | 41.92 | 42.00 | 41.75 | 41.81 | 1,025,263 |
| 41.81 | 42.01 | 41.78 | 41.85 | 699,353 |
| Backtest Cerevel Therapeutics | | | Cerevel Therapeutics History | | | Cerevel Therapeutics Valuation | Previous | Next |
Cerevel Therapeutics Trading Date Momentum on February 1, 2024
| On February 02 2024 Cerevel Therapeutics Holdings was traded for 41.85 at the closing time. The top price for the day was 42.01 and the lowest listed price was 41.78 . The trading volume for the day was 699.4 K. The trading history from February 2, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 0.10% . The overall trading delta against the current closing price is 2.42% . |
Cerevel Therapeutics Fundamentals Correlations and Trends
By evaluating Cerevel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cerevel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cerevel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cerevel Therapeutics Stock history
Cerevel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cerevel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cerevel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cerevel Therapeutics stock prices may prove useful in developing a viable investing in Cerevel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 162.1 M | 170.2 M | |
| Net Loss | -404.2 M | -424.4 M |
Cerevel Therapeutics Stock Technical Analysis
Cerevel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cerevel Therapeutics Period Price Range
Low | February 1, 2024
| High |
41.92 | 41.81 |
Cerevel Therapeutics May 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Cerevel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cerevel Therapeutics shares will generate the highest return on investment. By undertsting and applying Cerevel Therapeutics stock market strength indicators, traders can identify Cerevel Therapeutics Holdings entry and exit signals to maximize returns
| Accumulation Distribution | 6102.76 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 41.88 | |||
| Day Typical Price | 41.85 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | 0.74 |
Cerevel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cerevel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cerevel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cerevel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0244 | |||
| Jensen Alpha | 0.0031 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | (0.07) | |||
| Treynor Ratio | 0.0867 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cerevel Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Cerevel Stock analysis
When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.67) | Return On Assets (0.25) | Return On Equity (0.72) |
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.